FT  |  Companies

Novo Nordisk halves US price of weight-loss drug

诺和诺德将美国减肥药价格削半

Novo Nordisk halves US price of weight-loss drug
2026-02-24  376  简单
字体

The lower prices would increase the customer base, said Jamey Millar, executive vice-president of Novo’s US operations.

请登录后继续阅读完整文章

还没有账号?立即注册

成为会员后您将享受无限制的阅读体验,并可使用更多功能,了解更多


免责声明:本文来自网络公开资料,仅供学习交流,其观点和倾向不代表本站立场。